Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,treasuryStock,cash,totalCurrentLiabilities,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,shortTermInvestments,netReceivables,longTermDebt,accountsPayable,otherCurrentAssets,otherAssets,shortLongTermDebt,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,investments,changeToAccountReceivables,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,currency,exchange,marketCap,gmtOffSetMilliseconds,esgPopulated,tradeable,marketState,priceHint,regularMarketChangePercent,regularMarketDayRange,market,exchangeDataDelayedBy,shortName,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,dividendDate,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,fax,industry,address2
t0,DGNOF,1009848.0,17472100,,,-720023,,-720023,601616,-124453,-726069,-726069,,-10865,,,,0,75961,802030,200414,6046,,-720023,-720023,869883.0,1009848.0,1042.0,1879731.0,35367775.0,-43104267.0,8746340.0,236060.0,622017.0,8746340.0,304112.0,1543808.0,31811.0,1001467.0,216949.0,39080.0,417419.0,,,,0.0,-1712.0,-27494.0,448125.0,-4220.0,493000.0,-123330.0,-569743.0,25857.0,690.0,-17381.0,128643.0,-2402.0,,,921791.0,en-US,US,EQUITY,False,Delayed Quote,0.423925,1630330517,0.0,0.423925,0.423925,0.423925,5000,USD,PNK,16812654,-14400000,False,False,REGULAR,4,0.0,0.423925 - 0.423925,us_market,0,DIAGNOS INC,0.423925,0.0,0.0,0,0,finmb_3109295,Other OTC,DIAGNOS Inc.,CAD,3629,1200,0.243925,1.3551389,0.18 - 0.57,-0.14607498,-0.2562719,0.18,0.57,1556064000,-0.026,0.017,0.42777777,-0.0038527548,-0.00900644,0.44014493,-0.016219914,-0.0368513,24.936764,15,America/New_York,EDT,,,,0.57,0.18,0.4278,0.4401,3.63k,1.2k,17.47M,,53.33M,33.56%,0.44%,,,,,,,,,,,,"Apr 23, 2019",,1:10,"Apr 23, 2019","Mar 30, 2021","Jun 29, 2021",0.00%,-806.61%,-77.75%,-192.92%,295.34k,0.00,59.30%,-347.53k,-2.32M,-2.28M,-0.0260,,1.24M,0.02,451.42k,44.70,2.48,0.02,-1.51M,-924.46k,Value,J4Z 1A7,,"DIAGNOS Inc. provides software-based interpretation services primarily in Canada, the United States, Colombia, the United Arab Emirates, Bangladesh, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy. It also provides various consulting services in the fields of data analysis and artificial intelligence. The company was founded in 1998 and is headquartered in Brossard, Canada.",Brossard,450 678 8882,QC,1609372800,Canada,http://www.diagnos.ca,86400,7005 Taschereau Boulevard,450 678 8119,,Suite 265
t-1,DGNOF,1132153.0,17472100,,,-630024,,-630024,516786,-124356,-641142,-641142,,-10865,,,,0,61719,702861,186075,11118,,-630024,-630024,818189.0,1132153.0,4167.0,1950342.0,34756759.0,-42384244.0,8759638.0,359390.0,550063.0,8759638.0,327567.0,1590964.0,1811.0,1002656.0,175652.0,39166.0,190074.0,27151.0,30000.0,,69283.0,-504014.0,-42551.0,393357.0,-276800.0,419514.0,-599039.0,-488382.0,42931.0,13529.0,16394.0,166538.0,-17543.0,-500000.0,139690.0,1040901.0,en-US,US,EQUITY,False,Delayed Quote,0.423925,1630330517,0.0,0.423925,0.423925,0.423925,5000,USD,PNK,16812654,-14400000,False,False,REGULAR,4,0.0,0.423925 - 0.423925,us_market,0,DIAGNOS INC,0.423925,0.0,0.0,0,0,finmb_3109295,Other OTC,DIAGNOS Inc.,CAD,3629,1200,0.243925,1.3551389,0.18 - 0.57,-0.14607498,-0.2562719,0.18,0.57,1556064000,-0.026,0.017,0.42777777,-0.0038527548,-0.00900644,0.44014493,-0.016219914,-0.0368513,24.936764,15,America/New_York,EDT,,,,0.57,0.18,0.4278,0.4401,3.63k,1.2k,17.47M,,53.33M,33.56%,0.44%,,,,,,,,,,,,"Apr 23, 2019",,1:10,"Apr 23, 2019","Mar 30, 2021","Jun 29, 2021",0.00%,-806.61%,-77.75%,-192.92%,295.34k,0.00,59.30%,-347.53k,-2.32M,-2.28M,-0.0260,,1.24M,0.02,451.42k,44.70,2.48,0.02,-1.51M,-924.46k,Value,J4Z 1A7,,"DIAGNOS Inc. provides software-based interpretation services primarily in Canada, the United States, Colombia, the United Arab Emirates, Bangladesh, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy. It also provides various consulting services in the fields of data analysis and artificial intelligence. The company was founded in 1998 and is headquartered in Brossard, Canada.",Brossard,450 678 8882,QC,1609372800,Canada,http://www.diagnos.ca,86400,7005 Taschereau Boulevard,450 678 8119,,Suite 265
t-2,DGNOF,1167139.0,17472100,,,-572779,,-572779,482589,-86165,-568754,-568754,,-16174,,,,0,77877,646631,164042,-4025,,-572779,-572779,861344.0,1167139.0,10065.0,2028483.0,34354371.0,-41754220.0,8566988.0,958429.0,583480.0,8566988.0,352955.0,1644408.0,,503114.0,133387.0,39309.0,225065.0,20861.0,31120.0,,0.0,512193.0,-170621.0,498538.0,123999.0,687740.0,633909.0,-376822.0,18583.0,15575.0,-18581.0,53375.0,-3382.0,500000.0,139690.0,1060928.0,en-US,US,EQUITY,False,Delayed Quote,0.423925,1630330517,0.0,0.423925,0.423925,0.423925,5000,USD,PNK,16812654,-14400000,False,False,REGULAR,4,0.0,0.423925 - 0.423925,us_market,0,DIAGNOS INC,0.423925,0.0,0.0,0,0,finmb_3109295,Other OTC,DIAGNOS Inc.,CAD,3629,1200,0.243925,1.3551389,0.18 - 0.57,-0.14607498,-0.2562719,0.18,0.57,1556064000,-0.026,0.017,0.42777777,-0.0038527548,-0.00900644,0.44014493,-0.016219914,-0.0368513,24.936764,15,America/New_York,EDT,,,,0.57,0.18,0.4278,0.4401,3.63k,1.2k,17.47M,,53.33M,33.56%,0.44%,,,,,,,,,,,,"Apr 23, 2019",,1:10,"Apr 23, 2019","Mar 30, 2021","Jun 29, 2021",0.00%,-806.61%,-77.75%,-192.92%,295.34k,0.00,59.30%,-347.53k,-2.32M,-2.28M,-0.0260,,1.24M,0.02,451.42k,44.70,2.48,0.02,-1.51M,-924.46k,Value,J4Z 1A7,,"DIAGNOS Inc. provides software-based interpretation services primarily in Canada, the United States, Colombia, the United Arab Emirates, Bangladesh, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy. It also provides various consulting services in the fields of data analysis and artificial intelligence. The company was founded in 1998 and is headquartered in Brossard, Canada.",Brossard,450 678 8882,QC,1609372800,Canada,http://www.diagnos.ca,86400,7005 Taschereau Boulevard,450 678 8119,,Suite 265
t-3,DGNOF,1001603.0,17472100,,,-352181,,-352181,423927,-22391,-446318,-446318,,-11330,,,,0,79787,526105,102178,94137,,-352181,-352181,947107.0,1001603.0,11355.0,1948710.0,33666631.0,-41181441.0,8516413.0,324520.0,649860.0,8516413.0,368156.0,1549434.0,,1003114.0,161531.0,39515.0,113084.0,20841.0,31120.0,150000.0,0.0,208913.0,-24369.0,-32409.0,216158.0,687740.0,99800.0,-76704.0,18819.0,-24327.0,-8040.0,40500.0,-16760.0,250000.0,139690.0,899574.0,en-US,US,EQUITY,False,Delayed Quote,0.423925,1630330517,0.0,0.423925,0.423925,0.423925,5000,USD,PNK,16812654,-14400000,False,False,REGULAR,4,0.0,0.423925 - 0.423925,us_market,0,DIAGNOS INC,0.423925,0.0,0.0,0,0,finmb_3109295,Other OTC,DIAGNOS Inc.,CAD,3629,1200,0.243925,1.3551389,0.18 - 0.57,-0.14607498,-0.2562719,0.18,0.57,1556064000,-0.026,0.017,0.42777777,-0.0038527548,-0.00900644,0.44014493,-0.016219914,-0.0368513,24.936764,15,America/New_York,EDT,,,,0.57,0.18,0.4278,0.4401,3.63k,1.2k,17.47M,,53.33M,33.56%,0.44%,,,,,,,,,,,,"Apr 23, 2019",,1:10,"Apr 23, 2019","Mar 30, 2021","Jun 29, 2021",0.00%,-806.61%,-77.75%,-192.92%,295.34k,0.00,59.30%,-347.53k,-2.32M,-2.28M,-0.0260,,1.24M,0.02,451.42k,44.70,2.48,0.02,-1.51M,-924.46k,Value,J4Z 1A7,,"DIAGNOS Inc. provides software-based interpretation services primarily in Canada, the United States, Colombia, the United Arab Emirates, Bangladesh, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy. It also provides various consulting services in the fields of data analysis and artificial intelligence. The company was founded in 1998 and is headquartered in Brossard, Canada.",Brossard,450 678 8882,QC,1609372800,Canada,http://www.diagnos.ca,86400,7005 Taschereau Boulevard,450 678 8119,,Suite 265
